The role of endogenous IFN-β in the regulation of Th17 responses in patients with relapsing-remitting multiple sclerosis

Journal of Immunology

Volumn 192, Issue 12, 2014, Pages 5610-5617

  Tao, Yazhong ^a   Zhang, Xin ^a   Chopra, Manisha ^a   Kim, Ming Jeong ^a   Buch, Kinnari R ^a   Kong, Dehan ^b   Jin, Jianping ^c   Tang, Yunan ^a   Zhu, Hongtu ^b,c   Jewells, Valerie ^a   Markovic Plese, Silva ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 9;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CEREBROSPINAL FLUID; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; INTERFERON REGULATORY FACTOR 7 GENE; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TH17 CELL; TRANSCRIPTION REGULATION;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; CYTOKINES; FEMALE; HUMANS; INTERFERON-BETA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECEPTOR, INTERFERON ALPHA-BETA; RECURRENCE; SIGNAL TRANSDUCTION; TH17 CELLS;

EID: 84902161111     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302580     Document Type: Article

References (41)

1. Guo, B., E. Y. Chang, and G. Cheng. 2008. The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J. Clin. Invest. 118:1680-1690.
2. Prinz, M., H. Schmidt, A. Mildner, K. P. Knobeloch, U. K. Hanisch, J. Raasch, D. Merkler, C. Detje, I. Gutcher, J. Mages, et al. 2008. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 28:675-686.
3. Dalod, M., T. P. Salazar-Mather, L. Malmgaard, C. Lewis, C. Asselin-Paturel, F. Brière, G. Trinchieri, and C. A. Biron. 2002. Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195:517-528.
4. Le Bon, A., and D. F. Tough. 2002. Links between innate and adaptive immunity via type I interferon. Curr. Opin. Immunol. 14:432-436.
5. Thibault, D. L., K. L. Graham, L. Y. Lee, I. Balboni, P. J. Hertzog, and P. J. Utz. 2009. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus. Arthritis Res. Ther. 11:R112.
6. Taniguchi, T., K. Ogasawara, A. Takaoka, and N. Tanaka. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:623-655.
7. González-Navajas, J. M., J. Lee, M. David, and E. Raz. 2012. Immunomodulatory functions of type I interferons. Nat. Rev. Immunol. 12:125-135.
8. Salem, M., J. T. Mony, M. Løbner, R. Khorooshi, and T. Owens. 2011. Interferon regulatory factor-7 modulates experimental autoimmune encephalomyelitis in mice. J. Neuroinflammation 8:181.
9. Lock, C., G. Hermans, R. Pedotti, A. Brendolan, E. Schadt, H. Garren, A. Langer-Gould, S. Strober, B. Cannella, J. Allard, et al. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8:500-508.
10. Tzartos, J. S., M. A. Friese, M. J. Craner, J. Palace, J. Newcombe, M. M. Esiri, and L. Fugger. 2008. Interleukin-17 production in central nervous systeminfiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172:146-155.
11. Durelli, L., L. Conti, M. Clerico, D. Boselli, G. Contessa, P. Ripellino, B. Ferrero, P. Eid, and F. Novelli. 2009. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta. Ann. Neurol. 65:499-509.
12. Ishizu, T., M. Osoegawa, F. J. Mei, H. Kikuchi, M. Tanaka, Y. Takakura, M. Minohara, H. Murai, F. Mihara, T. Taniwaki, and J. Kira. 2005. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 128:988-1002.
13. Ramgolam, V. S., Y. Sha, J. Jin, X. Zhang, and S. Markovic-Plese. 2009. IFNbeta inhibits human Th17 cell differentiation. J. Immunol. 183:5418-5427.
14. Sweeney, C. M., R. Lonergan, S. A. Basdeo, K. Kinsella, L. S. Dungan, S. C. Higgins, P. J. Kelly, L. Costelloe, N. Tubridy, K. H. Mills, and J. M. Fletcher. 2011. IL-27 mediates the response to IFN-b therapy in multiple sclerosis patients by inhibiting Th17 cells. Brain Behav. Immun. 25:1170-1181.
15. Ramgolam, V. S., Y. Sha, K. L. Marcus, N. Choudhary, L. Troiani, M. Chopra, and S. Markovic-Plese. 2011. B cells as a therapeutic target for IFN-b in relapsing-remitting multiple sclerosis. J. Immunol. 186:4518-4526.
16. Chen, M., G. Chen, H. Nie, X. Zhang, X. Niu, Y. C. Zang, S. M. Skinner, J. Z. Zhang, J. M. Killian, and J. Hong. 2009. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS. Eur. J. Immunol. 39:2525-2536.
17. McDonald, W. I., A. Compston, G. Edan, D. Goodkin, H. P. Hartung, F. D. Lublin, H. F. McFarland, D. W. Paty, C. H. Polman, S. C. Reingold, et al. 2001. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50:121-127.
18. Zhang, X., Y. Tao, M. Chopra, M. Ahn, K. L. Marcus, N. Choudhary, H. Zhu, and S. Markovic-Plese. 2013. Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis. J. Immunol. 191:5867-5874.
19. Zhang, X., J. Jin, Y. Tang, D. Speer, D. Sujkowska, and S. Markovic-Plese. 2009. IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation. J. Immunol. 182:3928-3936.
20. Hua, J., K. Kirou, C. Lee, and M. K. Crow. 2006. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum. 54:1906-1916.
21. Lee, W. W., S. W. Kang, J. Choi, S. H. Lee, K. Shah, E. E. Eynon, R. A. Flavell, and I. Kang. 2010. Regulating human Th17 cells via differential expression of IL-1 receptor. Blood 115:530-540.
22. Van Waesberghe, J. H., W. Kamphorst, C. J. De Groot, M. A. Van Walderveen, J. A. Castelijns, R. Ravid, G. J. Lycklama À Nijeholt, P. Van Der Valk, C. H. Polman, A. J. Thompson, and F. Barkhof. 1999. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann. Neurol. 46:747-754.
23. Jabs, W. J., C. Hennig, R. Zawatzky, and H. Kirchner. 1999. Failure to detect antiviral activity in serum and plasma of healthy individuals displaying high activity in ELISA for IFN-alpha and IFN-beta. J. Interferon Cytokine Res. 19:463-469.
24. Feng, X., N. P. Reder, M. Yanamandala, A. Hill, B. S. Franek, T. B. Niewold, A. T. Reder, and A. Javed. 2012. Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis. J. Neurol. Sci. 313:48-53.
25. Jacobs, L. D., R. W. Beck, J. H. Simon, R. P. Kinkel, C. M. Brownscheidle, T. J. Murray, N. A. Simonian, P. J. Slasor, and A. W. Sandrock; CHAMPS Study Group. 2000. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N. Engl. J. Med. 343:898-904.
26. Shinohara, M. L., J. H. Kim, V. A. Garcia, and H. Cantor. 2008. Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. Immunity 29:68-78.
27. Wandinger, K. P., K. Wessel, P. Neustock, A. Siekhaus, and H. Kirchner. 1997. Diminished production of type-I interferons and interleukin-2 in patients with multiple sclerosis. J. Neurol. Sci. 149:87-93.
28. Stasiolek, M., A. Bayas, N. Kruse, A. Wieczarkowiecz, K. V. Toyka, R. Gold, and K. Selmaj. 2006. Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis. Brain 129:1293-1305.
29. Wilson, S. B., S. C. Kent, K. T. Patton, T. Orban, R. A. Jackson, M. Exley, S. Porcelli, D. A. Schatz, M. A. Atkinson, S. P. Balk, et al. 1998. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 391:177-181.
30. Redondo, M. J., P. A. Gottlieb, T. Motheral, C. Mulgrew, M. Rewers, S. Babu, E. Stephens, D. R. Wegmann, and G. S. Eisenbarth. 1999. Heterophile antimouse immunoglobulin antibodies may interfere with cytokine measurements in patients with HLA alleles protective for type 1A diabetes. Diabetes 48:2166-2170.
31. Van Der Voort, L. F., A. Vennegoor, A. Visser, D. L. Knol, B. M. Uitdehaag, F. Barkhof, C. B. Oudejans, C. H. Polman, and J. Killestein. 2010. Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS. Neurology 75:1228-1233.
32. Sanna, A., Y. M. Huang, G. Arru, M. L. Fois, H. Link, G. Rosati, and S. Sotgiu. 2008. Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1. Mult. Scler. 14:1199-1207.
33. Bayas, A., M. Stasiolek, N. Kruse, K. V. Toyka, K. Selmaj, and R. Gold. 2009. Altered innate immune response of plasmacytoid dendritic cells in multiple sclerosis. Clin. Exp. Immunol. 157:332-342.
34. Schwab, N., A. L. Zozulya, B. C. Kieseier, K. V. Toyka, and H. Wiendl. 2010. An imbalance of two functionally and phenotypically different subsets of plasmacytoid dendritic cells characterizes the dysfunctional immune regulation in multiple sclerosis. J. Immunol. 184:5368-5374.
35. Bailey-Bucktrout, S. L., S. C. Caulkins, G. Goings, J. A. Fischer, A. Dzionek, and S. D. Miller. 2008. Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. J. Immunol. 180:6457-6461.
36. Lande, R., V. Gafa, B. Serafini, E. Giacomini, A. Visconti, M. E. Remoli, M. Severa, M. Parmentier, G. Ristori, M. Salvetti, et al. 2008. Plasmacytoid dendritic cells in multiple sclerosis: intracerebral recruitment and impaired maturation in response to interferon-beta. J. Neuropathol. Exp. Neurol. 67:388-401.
37. Chang, S. H., J. M. Reynolds, B. P. Pappu, G. Chen, G. J. Martinez, and C. Dong. 2011. Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. Immunity 35:611-621.
38. Stürzebecher, S., K. P. Wandinger, A. Rosenwald, M. Sathyamoorthy, A. Tzou, P. Mattar, J. A. Frank, L. Staudt, R. Martin, and H. F. McFarland. 2003. Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis. Brain 126:1419-1429.
39. Comabella, M., and R. Martin. 2007. Genomics in multiple sclerosis-current state and future directions. J. Neuroimmunol. 187:1-8.
40. Wandinger, K. P., C. S. Stürzebecher, B. Bielekova, G. Detore, A. Rosenwald, L. M. Staudt, H. F. McFarland, and R. Martin. 2001. Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes. Ann. Neurol. 50:349-357.
41. Comabella, M., J. D. Lünemann, J. Río, A. Sánchez, C. López, E. Julià, M. Fernández, L. Nonell, M. Camiña-Tato, F. Deisenhammer, et al. 2009. A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis. Brain 132:3353-3365